Koji Harada

2.5k total citations
113 papers, 2.0k citations indexed

About

Koji Harada is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Koji Harada has authored 113 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 37 papers in Oncology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Koji Harada's work include Cancer-related Molecular Pathways (14 papers), Head and Neck Cancer Studies (14 papers) and Oral health in cancer treatment (13 papers). Koji Harada is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Head and Neck Cancer Studies (14 papers) and Oral health in cancer treatment (13 papers). Koji Harada collaborates with scholars based in Japan, United States and United Kingdom. Koji Harada's co-authors include Hideo Yoshida, Tarannum Ferdous, Yoshiya Ueyama, Yasuhiro Akai, Mitsunobu Sato, Masayuki Iwano, Yoshihiko Saito, Supriatno, Kimihiko Nakatani and Yukinari Yamaguchi and has published in prestigious journals such as PLoS ONE, Nuclear Physics B and Brain Research.

In The Last Decade

Koji Harada

106 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koji Harada Japan 21 792 486 365 300 293 113 2.0k
Xiaofei Chang United States 27 1.4k 1.8× 508 1.0× 467 1.3× 71 0.2× 345 1.2× 64 2.2k
Jonathan H. Axelrod Israel 25 919 1.2× 416 0.9× 367 1.0× 241 0.8× 149 0.5× 45 2.2k
Masaru Takenaka Japan 26 927 1.2× 430 0.9× 212 0.6× 229 0.8× 497 1.7× 145 2.1k
Shiyong Li United States 35 1.3k 1.6× 1.1k 2.3× 534 1.5× 93 0.3× 205 0.7× 124 3.4k
Gábor Méhes Hungary 25 1.1k 1.4× 798 1.6× 485 1.3× 60 0.2× 573 2.0× 170 2.8k
Tsuyoshi Noguchi Japan 31 1.8k 2.2× 1.0k 2.1× 666 1.8× 233 0.8× 532 1.8× 139 3.4k
Youssef H. Zeidan United States 23 1.1k 1.4× 277 0.6× 202 0.6× 67 0.2× 156 0.5× 78 1.8k
Stefano Ferrero Italy 28 1.1k 1.4× 422 0.9× 588 1.6× 89 0.3× 635 2.2× 99 2.4k
Gail Amir Israel 26 816 1.0× 657 1.4× 214 0.6× 236 0.8× 491 1.7× 75 2.9k
Guoliang Wang China 23 748 0.9× 353 0.7× 198 0.5× 43 0.1× 432 1.5× 149 2.0k

Countries citing papers authored by Koji Harada

Since Specialization
Citations

This map shows the geographic impact of Koji Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Harada more than expected).

Fields of papers citing papers by Koji Harada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Harada. The network helps show where Koji Harada may publish in the future.

Co-authorship network of co-authors of Koji Harada

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Harada. A scholar is included among the top collaborators of Koji Harada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Harada. Koji Harada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harada, Koji, et al.. (2025). Stomatitis Healing via Hydrogels Comprising Proline, Carboxyvinyl Polymer, and Water. Gels. 11(2). 108–108.
2.
Nishikawa, Jun, Yuki Shimizu, Akie Yanai, et al.. (2024). Far-ultraviolet irradiation at 222 nm destroys and sterilizes the biofilms formed by periodontitis pathogens. Journal of Microbiology Immunology and Infection. 57(4). 533–545. 5 indexed citations
3.
Harada, Koji, et al.. (2021). Amino Acids May Have Protective Effects on Salivary Glands of 5-FU-administered Mice. In Vivo. 36(1). 198–205. 6 indexed citations
4.
Schor, A. M., Kateřina Kaňková, Koji Harada, et al.. (2021). Migration Stimulating Factor (MSF): Its Role in the Tumour Microenvironment. Advances in experimental medicine and biology. 1329. 351–397. 3 indexed citations
5.
Tokuda, Kazuhiro, Takao Kitagawa, Byron Baron, et al.. (2018). CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells. Anticancer Research. 38(11). 6107–6111. 4 indexed citations
6.
Harada, Koji, et al.. (2017). Gimeracil enhances the antitumor effect of cisplatin in oral squamous cell carcinoma cells in vitro and in vivo. Oncology Letters. 14(3). 3349–3356. 8 indexed citations
7.
Harada, Koji, Tarannum Ferdous, Kenichiro Uchida, et al.. (2015). Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma. Supportive Care in Cancer. 24(2). 953–959. 32 indexed citations
9.
Harada, Koji, Tarannum Ferdous, Hiroaki Kobayashi, & Yoshiya Ueyama. (2014). Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-κB activity in human oral squamous cell carcinoma cell lines. International Journal of Oncology. 45(6). 2439–2445. 17 indexed citations
10.
Harada, Koji, et al.. (2013). Basic research on the combined effect of molecular-targeted agent Cetuximab and S-1 on oral squamous cell carcinomas. Toukeibu Gan. 39(3). 317–324. 1 indexed citations
12.
Harada, Koji, Yasuhiro Akai, Hiroki Takahashi, et al.. (2012). Significance of renal biopsy in patients with presumed diabetic nephropathy. Journal of Diabetes Investigation. 4(1). 88–93. 20 indexed citations
14.
Harada, Koji, et al.. (2009). Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.. PubMed. 29(4). 1263–70. 14 indexed citations
15.
Kouzu, Yukinao, Katsuhiro Uzawa, Masaki Kato, et al.. (2006). WISP-2 expression in human salivary gland tumors. International Journal of Molecular Medicine. 17(4). 567–73. 16 indexed citations
16.
Nishitani, Yoshiharu, Masayuki Iwano, Yukinari Yamaguchi, et al.. (2005). Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN. Kidney International. 68(3). 1078–1085. 89 indexed citations
17.
Supriatno, Koji Harada, Shinichi Kawaguchi, et al.. (2004). Characteristics of antitumor activity of mutant type p27Kip1 gene in an oral cancer cell line. Oral Oncology. 40(7). 679–687. 10 indexed citations
18.
Harada, Koji, Supriatno, Shin Yamamoto, et al.. (2003). Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1.. PubMed. 23(2B). 1441–8. 19 indexed citations
19.
Kawamata, Hitoshi, Koh‐ichi Nakashiro, Daisuke Uchida, et al.. (1997). Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines. International Journal of Cancer. 70(1). 120–127. 116 indexed citations
20.
Sato, Kenichi, et al.. (1991). Low Power Laser Therapy for Chronic Pain. Nippon Laser Igakkaishi. 11(4). 3–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026